Literature DB >> 26379943

Association of β-fibrinogen gene polymorphism and plasma fibrinogen and allergic purpura nephritis.

Jianhua Gong1, Qian Xu1, Fengqi Hu1, Hai Yuan1.   

Abstract

OBJECTIVE: To investigate the association of β-fibrinogen gene polymorphism with plasma fibrinogen and allergic purpura nephritis.
METHODS: We designed a case-control study (334 case and 300 control) to genotype the β-fibrinogen gene -455G/A polymorphism. The genotype and allele frequencies between the case and control group were compared. And we also compared the Fg concentration between different genotype.
RESULTS: In the case group, there were 143 cases of GA type, accounting for 42.8%; there were 168 cases of GG type, accounting for 50.3%; there were 23 cases of AA type, accounting for 6.9%. While in the control group, GG type was the most common. There were 228 cases of GG type, accounting for 76%; there were 66 cases of GA type, accounting for 22%; there was 6 case of AA type, accounting for 2%. The frequency of Fgβ-455G/A genotype between the two groups showed statistical significance (P<0.05). The levels of plasma Fg in the two groups showed statistical significance (P<0.01). In HSPN group Fgβ GA and AA-type the concentration of Fg [(4.2 ± 0.5) g/L], compared with the GG genotype [(3.1 ± 0.4) g/L], was significantly increased with statistical significance (P<0.01).
CONCLUSION: The Fgβ-455G/A polymorphism was associated with the risk for HSPN and Fg concentration.

Entities:  

Keywords:  allergic purpura nephritis; fibrinogen; gene polymorphism; β-fibrinogen

Year:  2015        PMID: 26379943      PMCID: PMC4565326     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  17 in total

1.  [Tubulointerstitial nephritis in the case of acute renal failure from sepsis after a cat bite].

Authors:  H Aihara; Y Kuroda; Y Sugawara; Y Tsuruya; S Yamada; K Tabei
Journal:  Nihon Jinzo Gakkai Shi       Date:  2001-05

2.  Detection of a complex that associates with the Bbeta fibrinogen G-455-A polymorphism.

Authors:  E T Brown; G M Fuller
Journal:  Blood       Date:  1998-11-01       Impact factor: 22.113

3.  The interaction of disagregin with the platelet fibrinogen receptor, glycoprotein IIb-IIIa.

Authors:  J Karczewski; T M Connolly
Journal:  Biochem Biophys Res Commun       Date:  1997-12-29       Impact factor: 3.575

4.  Association study of ACE and eNOS single nucleotide polymorphisms with Henoch-Schönlein purpura nephritis.

Authors:  Bo Di; Xinyuan Li; Liqun Song; Qianghu Wang; Suyan Liu
Journal:  Mol Med Rep       Date:  2012-08-10       Impact factor: 2.952

Review 5.  Nodular glomerulosclerosis: renal lesions in chronic smokers mimic chronic thrombotic microangiopathy and hypertensive lesions.

Authors:  Kelly V Liang; Eddie L Greene; Liem Som Oei; Matthew Lewin; Donna Lager; Sanjeev Sethi
Journal:  Am J Kidney Dis       Date:  2007-04       Impact factor: 8.860

6.  [Association of tumor necrosis factor-alpha gene polymorphisms with Henoch-Schonlein purpura nephritis in children].

Authors:  Jian-Jun Wang; Yan-Ping Shi; Yue Huang; Chun Wu; Xu-Chang Li
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2013-02

Review 7.  Adult Henoch-schönlein purpura in a patient with myelodysplastic syndrome and a history of follicular lymphoma.

Authors:  Matthew C Fox; Samantha Carter; Issa F Khouri; Sergio A Giralt; Victor G Prieto; Jason W Nash; Sharon R Hymes
Journal:  Cutis       Date:  2008-02

8.  [Is it justifiable to use antiplatelet drugs as a universal protection in patients with chronic glomerular damage?].

Authors:  J Duclos
Journal:  Rev Med Chil       Date:  1993-03       Impact factor: 0.553

9.  Posterior reversible encephalopathy syndrome in a child with Henoch-Schonlein purpura.

Authors:  Ali Kemal Sivrioglu; Mehmet Incedayi; Hakan Mutlu; Cihan Meral
Journal:  BMJ Case Rep       Date:  2013-08-14

Review 10.  The role of thrombomodulin lectin-like domain in inflammation.

Authors:  Yi-Heng Li; Cheng-Hsiang Kuo; Guey-Yueh Shi; Hua-Lin Wu
Journal:  J Biomed Sci       Date:  2012-03-27       Impact factor: 8.410

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.